New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
Fox Chase Cancer Center’s Biosample Repository Receives Reaccreditation From College of American Pathologists
PHILADELPHIA (March 11, 2025) — Fox Chase Cancer Center’s Biosample Repository Facility was recently awarded reaccreditation by the College of American Pathologists (CAP) based on the results of an on-site inspection.
A biorepository is used for the collection, processing, storage, dissemination, and analysis of biological samples and associated clinical data for research purposes. Repositories like the one at Fox Chase fill an essential role by facilitating translational research associated with clinical trials and basic research.
“The reaccreditation of the Biosample Repository Facility is a significant milestone, demonstrating our commitment to the highest standards in biospecimen management and research integrity,” said Johanna James, the facility’s manager.
“This achievement is a testament to the dedication and resilience of our staff, whose expertise and unwavering commitment ensure the highest quality, compliance, and reliability in our operations. This recognition further strengthens our role in supporting groundbreaking scientific research and innovation,” she added.
“This reaccreditation demonstrates to our patients that our facilities meet the highest quality standards,” said Jonathan Chernoff, MD, PhD, Cancer Center Director. “We are proud that our Biosample Repository Facility has been reaccredited by CAP, and we look forward to seeing how our facility will continue to serve as a vital tool in conducting groundbreaking research for the community.”
Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient outcomes. Fox Chase’s repository is one of more than 8,000 CAP-accredited facilities worldwide.
During the CAP accreditation process, which is designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management. These reviews help verify activities and reflect the most recent best practices.
With over 23,000 laboratory participants, in addition to accreditation, CAP offers proficiency testing/external quality assessment programs, quality improvement tools, and protocols and guidelines to ensure excellence in all areas across the laboratory. Built on a foundation of pathologist expertise, CAP partners with laboratories worldwide to elevate the quality of laboratory medicine with best-in-class solutions designed to drive operational excellence, achieve diagnostic confidence, and ensure the best patient care.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427